Statements (66)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:government_agency
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:BARDA
|
| gptkbp:addressed |
emerging infectious diseases
|
| gptkbp:aims_to |
national preparedness
develop medical countermeasures |
| gptkbp:appointed_by |
gptkb:healthcare_organization
|
| gptkbp:challenges |
budget constraints
|
| gptkbp:collaborated_with |
gptkb:Research_Institute
|
| gptkbp:collaborations |
gptkb:Police_Department
international health organizations |
| gptkbp:enhances |
community resilience
public health infrastructure |
| gptkbp:established |
gptkb:U._S._government
gptkb:2004 |
| gptkbp:facilitates |
development of rapid diagnostic tests
rapid response to biological threats |
| gptkbp:focuses_on |
biodefense
high-priority pathogens |
| gptkbp:founded |
gptkb:9/11_attacks
|
| https://www.w3.org/2000/01/rdf-schema#label |
Project Bio Shield
|
| gptkbp:is_criticized_for |
lack of transparency
slow response times |
| gptkbp:is_evaluated_by |
gptkb:government_agency
gptkb:Police_Department cost-effectiveness risk management strategies public health impact sustainability of programs effectiveness of countermeasures |
| gptkbp:is_informed_by |
gptkb:Research_Institute
|
| gptkbp:is_linked_to |
gptkb:Public_Health_Security_and_Bioterrorism_Preparedness_Act
global health security initiatives emergency preparedness training programs national vaccine strategy pandemic preparedness initiatives |
| gptkbp:is_monitored_by |
gptkb:Centers_for_Disease_Control_and_Prevention
|
| gptkbp:is_part_of |
gptkb:UN_Security_Council_Resolution
federal health initiatives national disaster response strategy national health security strategy federal emergency management efforts U. S. emergency response framework U. S. public health strategy federal biodefense strategy |
| gptkbp:is_protected_by |
civilian population
|
| gptkbp:is_related_to |
gptkb:Project_Bio_Shield_Act
|
| gptkbp:is_subject_to |
congressional oversight
|
| gptkbp:is_supported_by |
public-private partnerships
biomedical research community scientific advisory committees biodefense funding |
| gptkbp:led_to |
development of new therapies
improved surveillance systems public awareness of bioterrorism |
| gptkbp:part_of |
combat bioterrorism
|
| gptkbp:partnerships |
pharmaceutical companies
|
| gptkbp:promotes |
public health research
|
| gptkbp:receives_funding_from |
research and development
$5.6 billion U. S. federal budget |
| gptkbp:research_areas |
anthrax vaccines
|
| gptkbp:resulted_in |
increased vaccine production
|
| gptkbp:supports |
local health departments
stockpiling of vaccines |
| gptkbp:threats |
biological agents
|